[go: up one dir, main page]

BR0209861A - Processo para a produção de quinazolinas - Google Patents

Processo para a produção de quinazolinas

Info

Publication number
BR0209861A
BR0209861A BR0209861-0A BR0209861A BR0209861A BR 0209861 A BR0209861 A BR 0209861A BR 0209861 A BR0209861 A BR 0209861A BR 0209861 A BR0209861 A BR 0209861A
Authority
BR
Brazil
Prior art keywords
formula
production
compound
quinazolines
solvate
Prior art date
Application number
BR0209861-0A
Other languages
English (en)
Inventor
Jens Bertil Ahman
Paul Blaise Hodgson
Sarah Jane Lewandowski
Robert Walton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR0209861A publication Critical patent/BR0209861A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"PROCESSO PARA A PRODUçãO DE QUINAZOLINAS". A invenção refere-se a um processo para a produção de um composto de fórmula (A) ou de um sal ou solvato farmaceuticamente aceitável deste: o qual compreende a condensação de um composto de fórmula (B) com um composto de fórmula (C): Os compostos de fórmula (A) são proveitosos no tratamento da hiperplasia prostática benigna.
BR0209861-0A 2001-05-18 2002-05-10 Processo para a produção de quinazolinas BR0209861A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0112061.7A GB0112061D0 (en) 2001-05-18 2001-05-18 Process for the production of quinazolines
PCT/IB2002/001748 WO2002094815A1 (en) 2001-05-18 2002-05-10 Process for the production of quinazolines

Publications (1)

Publication Number Publication Date
BR0209861A true BR0209861A (pt) 2004-06-15

Family

ID=9914812

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209861-0A BR0209861A (pt) 2001-05-18 2002-05-10 Processo para a produção de quinazolinas

Country Status (10)

Country Link
EP (1) EP1387839B1 (pt)
JP (1) JP2004537519A (pt)
AT (1) ATE319707T1 (pt)
BR (1) BR0209861A (pt)
CA (1) CA2447233A1 (pt)
DE (1) DE60209709T2 (pt)
ES (1) ES2255615T3 (pt)
GB (1) GB0112061D0 (pt)
MX (1) MXPA03010504A (pt)
WO (1) WO2002094815A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE635308A (pt) * 1962-07-23
GB1477607A (en) * 1975-03-13 1977-06-22 Roche Products Ltd 2-amidino-4-hydroxy-1,2,3,4-tetrahydroisoquinoline and salts thereof
GB8719378D0 (en) * 1987-08-15 1987-09-23 Pfizer Ltd Antiarrythmic agents
GB9700504D0 (en) * 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
DE60209709T2 (de) 2006-10-12
EP1387839A1 (en) 2004-02-11
EP1387839B1 (en) 2006-03-08
MXPA03010504A (es) 2004-03-02
GB0112061D0 (en) 2001-07-11
ATE319707T1 (de) 2006-03-15
DE60209709D1 (de) 2006-05-04
WO2002094815A1 (en) 2002-11-28
ES2255615T3 (es) 2006-07-01
CA2447233A1 (en) 2002-11-28
JP2004537519A (ja) 2004-12-16

Similar Documents

Publication Publication Date Title
FIC20210022I1 (fi) tukatinibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan tai solvaatin muodossa
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
CY1105573T1 (el) Πυρρολο πυριμιδινες ως ανασταλτικοι παραγοντες των πρωτεασων κυστεϊνης
CY1113487T1 (el) Νεα παραγωγα μανδελικου οξεος και η χρηση τους ως αναστολεις θροβινης
CY1108041T1 (el) Αναστολεις της rho-κινασης
NO20041493L (no) Kjemiske forbindelser.
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
CY1105374T1 (el) Αναστολεις παραγοντα χα και αλλων πρωτεασων σepινης που ενεχονται στον καταρρακτη πηξης
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
NO20033593L (no) Kinazoliner som MMP-13 inhibitorer
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
CY1107149T1 (el) Νεα παραγωγα αμιδινοβενζυλαμινης και χρηση τους ως αναστολεων θρομβινης
DK1606242T3 (da) Azidfri fremgangsmåde til fremstilling af 1,2-diaminoforbindelser
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DK1465625T3 (da) Opløste topoisomerase-gifte
WO2003082268A3 (en) Hemiasterlin derivatives and uses thereof in the treatment of cancer
MXPA04006041A (es) Antivirales de piridoquinoxalina.
SE0003476D0 (sv) Compounds
ATE516031T1 (de) Verbindungen gegen krebs
EP1453506A4 (en) Topoisomerase GIFT FUNDS
BR0109512A (pt) Imidazopiridinas tricìclicas
HN2002000197A (es) Proceso para la produccion de quinazolinas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.